Related Experiment Video
Updated: Jun 29, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
Basic research into the mechanisms responsible for postmenopausal hypertension
1Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Insights
Postmenopausal hypertension is a significant risk factor for cardiovascular disease (CVD) in women. The aging female spontaneously hypertensive rat (SHR) offers a new model to study the mechanisms behind this condition.
Area of Science:
- Endocrinology and cardiovascular science
- Reproductive biology and aging
Background:
- Cardiovascular disease (CVD) risk, particularly hypertension, increases in women after menopause.
- Mechanisms driving postmenopausal hypertension, including hormonal shifts and increased oxidative stress, are not fully understood.
- A lack of suitable animal models has hindered research into postmenopausal hypertension.
Purpose of the Study:
- To review potential mechanisms contributing to postmenopausal hypertension.
- To introduce and characterize the aging female spontaneously hypertensive rat (SHR) as a model for postmenopausal hypertension.
Main Methods:
- Review of existing literature on hormonal changes, renin-angiotensin system, endothelin, oxidative stress, obesity, type 2 diabetes, and sympathetic nervous system activation in postmenopausal women.
- Characterization of the aging female SHR for its humoral and physiological similarities to postmenopausal women.
Main Results:
- The aging female SHR exhibits humoral characteristics mirroring those of postmenopausal women.
- This model presents a viable tool for investigating the underlying causes of postmenopausal hypertension.
Conclusions:
- Understanding the mechanisms of postmenopausal hypertension is crucial for CVD prevention in women.
- The aging female SHR serves as a valuable preclinical model for studying postmenopausal hypertension and testing potential interventions.
Abstract:
Women typically experience increased cardiovascular disease (CVD) following menopause. Major risk factors for CVD include hypertension and, after menopause, blood pressure increases in women. The mechanism(s) responsible for this increase are not determined. Changes in oestrogen/androgen ratios, possible activation of the renin-angiotensin system, and increases in endothelin and oxidative stress, are hallmarks in postmenopausal women. Obesity, type 2 diabetes and activation of the sympathetic nervous system may also play important roles. However, progress in clarifying the mechanisms responsible for postmenopausal hypertension has been hampered by lack of a suitable animal model. We have recently characterised the ageing female spontaneously hypertensive rat (SHR) as a model of postmenopausal hypertension, since this strain exhibits many of the humoral characteristics of postmenopausal women. This review discusses some of the mechanisms that could play a role in postmenopausal hypertension, as well as the characteristics of the ageing female SHR as a model.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
05:57The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Related Concept Videos
Hormonal Regulation
Hypertension and Regulation of Blood Pressure
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies